The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer.

Crespo GV, Ortiz J, O'Farrill EH, Vlaar CP, Inyushin M, Kucheryavykh Y, Kucheryavykh L. The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer. Mol Med. 2023 06 14; 29(1):75.

View in: PubMed

subject areas

Animals
Cell Survival
Flow Cytometry
Focal Adhesion Kinase 2
Humans
Mice

authors with profiles

Mikhail Inyushin
Cornelis Vlaar
Lilia Kucheryavykh

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support